Biotype as determinant of natural immunising effect of cholera
To test the hypothesis that clinical Vibrio cholerae 01 infections protect against recurrent cholera, treated cholera episodes in a rural Bangladesh population of 188 153 people who were followed between 1985 and 1988 were analysed. Of the 2214 people with initial episodes of cholera, 7 had a second...
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 1991-04, Vol.337 (8746), p.883-884 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 884 |
|---|---|
| container_issue | 8746 |
| container_start_page | 883 |
| container_title | The Lancet (British edition) |
| container_volume | 337 |
| creator | Clemens, J.D. van Loon, F. Sack, D.A. Rao, M.R. Ahmed, F. Chakraborty, J. Kay, B.A. Khan, M.R. Yunus, M. Harris, J.R. Clemens, J.D. Rao, M.R. Sack, D.A. Harris, J.R. Clemens, J.D. Rao, M.R. Svennerholm, A-M. Holmgren, J. |
| description | To test the hypothesis that clinical
Vibrio cholerae 01 infections protect against recurrent cholera, treated cholera episodes in a rural Bangladesh population of 188 153 people who were followed between 1985 and 1988 were analysed. Of the 2214 people with initial episodes of cholera, 7 had a second episode. The incidence of cholera was 61% lower in subjects who had had an earlier episode than in those without such an episode. Whereas initial episodes of classical cholera were associated with complete protection against subsequent cholera, initial episodes of El Tor cholera were associated with negligible protection. |
| doi_str_mv | 10.1016/0140-6736(91)90207-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80506818</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0140673691902076</els_id><sourcerecordid>1693884</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-9da5e7b8ab7cdc10305ed64a5df559c89d812110997670af161ad12a1ddd762d3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMouq7-A4XiQfRQnek2SXMRVPyCBS8K3kI2mWqkH2vSCvvv7e6KggdPc3ifd2Z4GDtAOENAcQ6YQyrkRJwoPFWQgUzFBhthLvOU5_Jlk41-kB22G-M7AOQC-DbbRiEzJXHELq582y3mlJiYOOoo1L4xTZe0ZdKYrg-mSnxd942PvnlNqCzJrkL71lYUzB7bKk0Vaf97jtnz7c3T9X06fbx7uL6cpnZS5F2qnOEkZ4WZSesswgQ4OZEb7krOlS2UKzBDBKWkkGBKFGgcZgadc1JkbjJmx-u989B-9BQ7XftoqapMQ20fdQEcRIHFAB79Ad_bPjTDbxpVoRTwbAnla8iGNsZApZ4HX5uw0Ah66VYvxemlOK1Qr9xqMdQOv3f3s5rcb2ktc8gv1jkNJj49BR2tp8aS82HQpl3r_z_wBR8Gh0w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198990528</pqid></control><display><type>article</type><title>Biotype as determinant of natural immunising effect of cholera</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><source>Business Source Complete</source><creator>Clemens, J.D. ; van Loon, F. ; Sack, D.A. ; Rao, M.R. ; Ahmed, F. ; Chakraborty, J. ; Kay, B.A. ; Khan, M.R. ; Yunus, M. ; Harris, J.R. ; Clemens, J.D. ; Rao, M.R. ; Sack, D.A. ; Harris, J.R. ; Clemens, J.D. ; Rao, M.R. ; Svennerholm, A-M. ; Holmgren, J.</creator><creatorcontrib>Clemens, J.D. ; van Loon, F. ; Sack, D.A. ; Rao, M.R. ; Ahmed, F. ; Chakraborty, J. ; Kay, B.A. ; Khan, M.R. ; Yunus, M. ; Harris, J.R. ; Clemens, J.D. ; Rao, M.R. ; Sack, D.A. ; Harris, J.R. ; Clemens, J.D. ; Rao, M.R. ; Svennerholm, A-M. ; Holmgren, J.</creatorcontrib><description>To test the hypothesis that clinical
Vibrio cholerae 01 infections protect against recurrent cholera, treated cholera episodes in a rural Bangladesh population of 188 153 people who were followed between 1985 and 1988 were analysed. Of the 2214 people with initial episodes of cholera, 7 had a second episode. The incidence of cholera was 61% lower in subjects who had had an earlier episode than in those without such an episode. Whereas initial episodes of classical cholera were associated with complete protection against subsequent cholera, initial episodes of El Tor cholera were associated with negligible protection.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/0140-6736(91)90207-6</identifier><identifier>PMID: 1672971</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Bangladesh ; Child ; Child, Preschool ; Cholera ; Cholera - immunology ; Cholera Vaccines - immunology ; Female ; Humans ; Immunity (Disease) ; Immunity, Active ; Medical research ; Population Surveillance ; Prospective Studies ; Recurrence ; Vibrio cholerae - immunology ; Waterborne diseases</subject><ispartof>The Lancet (British edition), 1991-04, Vol.337 (8746), p.883-884</ispartof><rights>1991</rights><rights>Copyright Lancet Ltd. Apr 13, 1991</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-9da5e7b8ab7cdc10305ed64a5df559c89d812110997670af161ad12a1ddd762d3</citedby><cites>FETCH-LOGICAL-c384t-9da5e7b8ab7cdc10305ed64a5df559c89d812110997670af161ad12a1ddd762d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0140-6736(91)90207-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1672971$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Clemens, J.D.</creatorcontrib><creatorcontrib>van Loon, F.</creatorcontrib><creatorcontrib>Sack, D.A.</creatorcontrib><creatorcontrib>Rao, M.R.</creatorcontrib><creatorcontrib>Ahmed, F.</creatorcontrib><creatorcontrib>Chakraborty, J.</creatorcontrib><creatorcontrib>Kay, B.A.</creatorcontrib><creatorcontrib>Khan, M.R.</creatorcontrib><creatorcontrib>Yunus, M.</creatorcontrib><creatorcontrib>Harris, J.R.</creatorcontrib><creatorcontrib>Clemens, J.D.</creatorcontrib><creatorcontrib>Rao, M.R.</creatorcontrib><creatorcontrib>Sack, D.A.</creatorcontrib><creatorcontrib>Harris, J.R.</creatorcontrib><creatorcontrib>Clemens, J.D.</creatorcontrib><creatorcontrib>Rao, M.R.</creatorcontrib><creatorcontrib>Svennerholm, A-M.</creatorcontrib><creatorcontrib>Holmgren, J.</creatorcontrib><title>Biotype as determinant of natural immunising effect of cholera</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>To test the hypothesis that clinical
Vibrio cholerae 01 infections protect against recurrent cholera, treated cholera episodes in a rural Bangladesh population of 188 153 people who were followed between 1985 and 1988 were analysed. Of the 2214 people with initial episodes of cholera, 7 had a second episode. The incidence of cholera was 61% lower in subjects who had had an earlier episode than in those without such an episode. Whereas initial episodes of classical cholera were associated with complete protection against subsequent cholera, initial episodes of El Tor cholera were associated with negligible protection.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Bangladesh</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cholera</subject><subject>Cholera - immunology</subject><subject>Cholera Vaccines - immunology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunity (Disease)</subject><subject>Immunity, Active</subject><subject>Medical research</subject><subject>Population Surveillance</subject><subject>Prospective Studies</subject><subject>Recurrence</subject><subject>Vibrio cholerae - immunology</subject><subject>Waterborne diseases</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMouq7-A4XiQfRQnek2SXMRVPyCBS8K3kI2mWqkH2vSCvvv7e6KggdPc3ifd2Z4GDtAOENAcQ6YQyrkRJwoPFWQgUzFBhthLvOU5_Jlk41-kB22G-M7AOQC-DbbRiEzJXHELq582y3mlJiYOOoo1L4xTZe0ZdKYrg-mSnxd942PvnlNqCzJrkL71lYUzB7bKk0Vaf97jtnz7c3T9X06fbx7uL6cpnZS5F2qnOEkZ4WZSesswgQ4OZEb7krOlS2UKzBDBKWkkGBKFGgcZgadc1JkbjJmx-u989B-9BQ7XftoqapMQ20fdQEcRIHFAB79Ad_bPjTDbxpVoRTwbAnla8iGNsZApZ4HX5uw0Ah66VYvxemlOK1Qr9xqMdQOv3f3s5rcb2ktc8gv1jkNJj49BR2tp8aS82HQpl3r_z_wBR8Gh0w</recordid><startdate>19910413</startdate><enddate>19910413</enddate><creator>Clemens, J.D.</creator><creator>van Loon, F.</creator><creator>Sack, D.A.</creator><creator>Rao, M.R.</creator><creator>Ahmed, F.</creator><creator>Chakraborty, J.</creator><creator>Kay, B.A.</creator><creator>Khan, M.R.</creator><creator>Yunus, M.</creator><creator>Harris, J.R.</creator><creator>Clemens, J.D.</creator><creator>Rao, M.R.</creator><creator>Sack, D.A.</creator><creator>Harris, J.R.</creator><creator>Clemens, J.D.</creator><creator>Rao, M.R.</creator><creator>Svennerholm, A-M.</creator><creator>Holmgren, J.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>ASE</scope><scope>C1K</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>KB~</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>19910413</creationdate><title>Biotype as determinant of natural immunising effect of cholera</title><author>Clemens, J.D. ; van Loon, F. ; Sack, D.A. ; Rao, M.R. ; Ahmed, F. ; Chakraborty, J. ; Kay, B.A. ; Khan, M.R. ; Yunus, M. ; Harris, J.R. ; Clemens, J.D. ; Rao, M.R. ; Sack, D.A. ; Harris, J.R. ; Clemens, J.D. ; Rao, M.R. ; Svennerholm, A-M. ; Holmgren, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-9da5e7b8ab7cdc10305ed64a5df559c89d812110997670af161ad12a1ddd762d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Bangladesh</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cholera</topic><topic>Cholera - immunology</topic><topic>Cholera Vaccines - immunology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunity (Disease)</topic><topic>Immunity, Active</topic><topic>Medical research</topic><topic>Population Surveillance</topic><topic>Prospective Studies</topic><topic>Recurrence</topic><topic>Vibrio cholerae - immunology</topic><topic>Waterborne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Clemens, J.D.</creatorcontrib><creatorcontrib>van Loon, F.</creatorcontrib><creatorcontrib>Sack, D.A.</creatorcontrib><creatorcontrib>Rao, M.R.</creatorcontrib><creatorcontrib>Ahmed, F.</creatorcontrib><creatorcontrib>Chakraborty, J.</creatorcontrib><creatorcontrib>Kay, B.A.</creatorcontrib><creatorcontrib>Khan, M.R.</creatorcontrib><creatorcontrib>Yunus, M.</creatorcontrib><creatorcontrib>Harris, J.R.</creatorcontrib><creatorcontrib>Clemens, J.D.</creatorcontrib><creatorcontrib>Rao, M.R.</creatorcontrib><creatorcontrib>Sack, D.A.</creatorcontrib><creatorcontrib>Harris, J.R.</creatorcontrib><creatorcontrib>Clemens, J.D.</creatorcontrib><creatorcontrib>Rao, M.R.</creatorcontrib><creatorcontrib>Svennerholm, A-M.</creatorcontrib><creatorcontrib>Holmgren, J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Newsstand Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Clemens, J.D.</au><au>van Loon, F.</au><au>Sack, D.A.</au><au>Rao, M.R.</au><au>Ahmed, F.</au><au>Chakraborty, J.</au><au>Kay, B.A.</au><au>Khan, M.R.</au><au>Yunus, M.</au><au>Harris, J.R.</au><au>Clemens, J.D.</au><au>Rao, M.R.</au><au>Sack, D.A.</au><au>Harris, J.R.</au><au>Clemens, J.D.</au><au>Rao, M.R.</au><au>Svennerholm, A-M.</au><au>Holmgren, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biotype as determinant of natural immunising effect of cholera</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>1991-04-13</date><risdate>1991</risdate><volume>337</volume><issue>8746</issue><spage>883</spage><epage>884</epage><pages>883-884</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>To test the hypothesis that clinical
Vibrio cholerae 01 infections protect against recurrent cholera, treated cholera episodes in a rural Bangladesh population of 188 153 people who were followed between 1985 and 1988 were analysed. Of the 2214 people with initial episodes of cholera, 7 had a second episode. The incidence of cholera was 61% lower in subjects who had had an earlier episode than in those without such an episode. Whereas initial episodes of classical cholera were associated with complete protection against subsequent cholera, initial episodes of El Tor cholera were associated with negligible protection.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>1672971</pmid><doi>10.1016/0140-6736(91)90207-6</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 1991-04, Vol.337 (8746), p.883-884 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80506818 |
| source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE; Business Source Complete |
| subjects | Adolescent Adult Bangladesh Child Child, Preschool Cholera Cholera - immunology Cholera Vaccines - immunology Female Humans Immunity (Disease) Immunity, Active Medical research Population Surveillance Prospective Studies Recurrence Vibrio cholerae - immunology Waterborne diseases |
| title | Biotype as determinant of natural immunising effect of cholera |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T15%3A42%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biotype%20as%20determinant%20of%20natural%20immunising%20effect%20of%20cholera&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Clemens,%20J.D.&rft.date=1991-04-13&rft.volume=337&rft.issue=8746&rft.spage=883&rft.epage=884&rft.pages=883-884&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/0140-6736(91)90207-6&rft_dat=%3Cproquest_cross%3E1693884%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=198990528&rft_id=info:pmid/1672971&rft_els_id=0140673691902076&rfr_iscdi=true |